Molecular genetics of late-onset Alzheimer's disease

Annals of Human Genetics
M Ilyas Kamboh

Abstract

Late-onset Alzheimer's disease (AD) is a complex and multifactorial disease with the possible involvement of several genes. Apolipoprotein E (APOE), especially the APOE*4 allele, has been established as a strong susceptibility marker that accounts for nearly 30% of the risk in late-onset AD. However, as the APOE*4 allele is neither necessary nor sufficient for the development of AD, it emphasizes the involvement of other genetic and/or environmental factors which, alone or in conjunction with APOE*4, can modify the risk of AD. Recently, genome-wide linkage or linkage disequilibrium studies on late-onset AD have provided informative data for the existence of multiple putative genes for AD on several chromosomes, with the strongest evidence on chromosomes 12, 10, 9 and 6. This paper attempts to review the current progress on the identification of additional genetic loci for late-onset AD.

References

Aug 1, 1984·Psychological Medicine·E B Renvoize
Apr 1, 1996·Genomics·J L HainesM A Pericak-Vance
Jun 1, 1996·Annals of Neurology·M A Pericak-VanceJ L Haines
Oct 23, 1997·JAMA : the Journal of the American Medical Association·M A Pericak-VanceJ L Haines
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·K OkaT Masaki
Aug 26, 1998·JAMA : the Journal of the American Medical Association·E RogaevaP H St George-Hyslop
Aug 26, 1998·JAMA : the Journal of the American Medical Association·W S WuA Goate
Sep 2, 1998·Acta Neurologica Scandinavica·O CombarrosJ Berciano
Jan 23, 1999·Nature Genetics·P O Brown, D Botstein
Jan 23, 1999·Health Affairs·J LeonP J Neumann
Feb 5, 1999·Human Molecular Genetics·P KehoeM J Owen
Mar 11, 1999·Annals of Neurology·C BalleriniS Sorbi
Apr 15, 1999·Neuroscience Letters·D MiddletonD Neill
Aug 12, 1999·American Journal of Human Genetics·S B RobertsK S Kendler
Aug 24, 1999·The Journal of Biological Chemistry·Z BingW S Liao

❮ Previous
Next ❯

Citations

Nov 13, 2008·Archives of Neurology·Joseph H LeeUNKNOWN National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group
Jan 11, 2005·Neurotoxicity Research·Tomás PalomoRichard M Kostrzewa
Mar 13, 2012·Journal of Neurology·Lai QianYun Xu
Mar 15, 2012·Journal of Molecular Neuroscience : MN·Ying KongKe-jun Nan
Jun 1, 2005·Mutation Research·C T McMurray
Sep 20, 2011·International Psychogeriatrics·Mary Ganguli, Eric Rodriguez
Oct 25, 2007·European Journal of Human Genetics : EJHG·Anna SillénCaroline Graff
Nov 17, 2005·Molecular Psychiatry·A SillénC Graff
Mar 5, 2005·The New England Journal of Medicine·Thomas D Bird
Apr 17, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Thomas D Bird
Mar 5, 2008·Alzheimer Disease and Associated Disorders·Lissy JarvikAlan B Zonderman
Feb 15, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·Paola BossùGianfranco Spalletta
Apr 29, 2006·Dementia and Geriatric Cognitive Disorders·Yvonne DavidsonDavid M A Mann
Apr 9, 2010·Dementia and Geriatric Cognitive Disorders·Yi-Fang ChuangPeter P Zandi
May 17, 2012·Dementia and Geriatric Cognitive Disorders Extra· Toure Ndiaye
Nov 4, 2010·Journal of Geriatric Psychiatry and Neurology·Lynn M BekrisDebby W Tsuang
Aug 4, 2007·BMC Medical Genetics·Ritesh KaushalRanjan Deka
Dec 10, 2013·Behavioural Brain Research·David ChengTim Karl
Dec 19, 2007·Pharmacogenomics·Yonghong Li, Andrew Grupe
Oct 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yonghong LiAndrew Grupe
Mar 7, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Matt J NevilleFredrik Karpe
Jul 6, 2007·Expert Review of Neurotherapeutics·Remi DosunmuNasser H Zawia
Sep 21, 2007·Journal of Neuropathology and Experimental Neurology·Robert E Mrak, W Sue T Griffin
Oct 19, 2006·Journal of Biomedicine & Biotechnology·Barney E DwyerMark A Smith
Sep 18, 2012·Ageing Research Reviews·Chaoyun LiHermann Schluesener
Jun 24, 2016·Nature Reviews. Neuroscience·Bing YaoHongjun Song
Mar 7, 2006·Experimental Neurology·Ward A PedersenGleb R Haynatzki
Mar 25, 2008·Advances in Genetics·John P RiceJonathan Corbett
Jul 31, 2007·Neurologic Clinics·Nilüfer Ertekin-Taner
Nov 6, 2012·Revista española de geriatría y gerontología·Carlos Fernández-ViaderoDámaso Crespo Santiago
Mar 1, 2006·Neurobiology of Disease·Faiza BensemainJean-Charles Lambert
Sep 18, 2007·Advanced Drug Delivery Reviews·Edward RockensteinEliezer Masliah

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.